Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

NCT07127172 is registered in ClinicalTrials.gov with Neuralink Corp as lead sponsor.

NCT NCT07127172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07127172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Lead sponsor
Neuralink Corp
Phase
Not applicable
Overall status
Recruiting
Start date
July 31, 2025
Completion date
February 28, 2031
Enrollment
7 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis (als), brain stem stroke, cervical spinal cord injury, motor neuron disease, quadriplegia, quadriplegia/tetraplegia, spinal cord injury, spinal cord injury (quadraplegia), tetraplegia/tetraparesis